Co-Authors
This is a "connection" page, showing publications co-authored by Spinello Antinori and Cecilia Bonazzetti.
Connection Strength
3.870
-
Remdesivir in moderate to severe COVID-19: A matter of time? Pharmacol Res. 2021 08; 170:105711.
Score: 0.949
-
Comment on: Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU. J Antimicrob Chemother. 2021 05 12; 76(6):1650-1651.
Score: 0.945
-
Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study. Crit Care Med. 2021 01 01; 49(1):e31-e40.
Score: 0.922
-
SARS-COV-2 infection: Across the border into the family. Travel Med Infect Dis. 2020 Jul - Aug; 36:101784.
Score: 0.222
-
Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge. Travel Med Infect Dis. 2020 Nov - Dec; 38:101752.
Score: 0.221
-
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899.
Score: 0.220
-
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? Autoimmun Rev. 2020 07; 19(7):102564.
Score: 0.220
-
Impact of gender on patients hospitalized for SARS-COV-2 infection: A prospective observational study. J Med Virol. 2021 07; 93(7):4597-4602.
Score: 0.059
-
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients. Drugs Aging. 2021 04; 38(4):341-346.
Score: 0.058
-
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020 08; 158:104931.
Score: 0.055